Lineage Cell Therapeutics Inc (AMEX:LCTX) concluded the trading at $0.47 on Wednesday, April 23 with a rise of 9.82% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.43 and 5Y monthly beta was reading 1.327 with its price kept floating in the range of $0.421 and $0.472 on the day. Considering stock’s 52-week price range provides that LCTX hit a high price of $1.40 and saw its price falling to a low level of $0.37 during that period. Over a period of past 1-month, stock came subtracting -11.99% in its value.
In contrast, when we review LCTX stock’s current outlook then short term indicators are assigning it an average of 50% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the LCTX stock which is currently positioned at 0. It further provides that stock’s current price level is 8.25% away from its 20-day simple moving average and is -9.41% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 52.37 while volatility remained at 8.48% over the past week which changes to 9.11% when measuring it over the past month. Beta is valued at 1.41, while measure of average true range or ATR is currently at 0.04.
Having a second look at Lineage Cell Therapeutics Inc (AMEX:LCTX) provides that stock’s average daily trading volume for 3 months was 1.42 million, while it jumped to 1084800 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 228.36 million.
The percentage of outstanding shares held by the insiders is 0.44% while it is 51.19% for the institutional holders. The figures also indicate that as of 2025-03-31, number of stock’s short shares was 26.64 million which implies a short ratio of 14.76. This shows up a 1849.00 of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 22.03 million in the previous month. Subtraction of -6.07% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
